Walder Wyss advised Swixx Biopharma AG in this transaction, while Baker McKenzie advised MxEP. Mérieux Equity Partners, France (MxEP) has agreed to invest EUR 40 million…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
